A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/00 (2006.01)
Patent
CA 2533499
The invention concerns the use of a gaseous mixture containing gas xenon and gas nitrous oxide, and advantageously oxygen, for making all or part of an inhalable medicine for preventing or treating neurointoxication in a human. The xenon/nitrous oxide mixture of the invention acts on one or more cerebral receptors to reduce the release and/or the effects of dopamine, glutamate, serotonin, taurin, GABA, noradrenaline and/or any other neurotransmitter. The proportion by volume of xenon of the mixture ranges between 5 and 45 %, and the proportion by volume of nitrous oxide ranges between 10 and 50 %, the balance is preferably oxygen.
L'invention porte sur une utilisation d'un mélange gazeux contenant du xénon gazeux et du protoxyde d'azote gazeux, et avantageusement de l'oxygène, pour fabriquer tout ou partie d'un médicament inhalable destiné à prévenir ou à traiter une neuro-intoxication chez l'homme. Le mélange xénon/protoxyde d'azote de l'invention agit sur un ou des récepteurs cérébraux de manière à diminuer la libération et/ou les effets de dopamine, glutamate, serotonine, taurine, GABA, noradrénaline et/ou de tout autre neurotransmetteur. La proportion volumique de xénon du mélange est comprise entre 5 et 45%, et la proportion volumique de protoxyde d'azote est comprise entre 10 et 50%, de préférence le reste est de l'oxygène.
Abraini Jacques
Lemaire Marc
Air Liquide Sante (international)
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Inhalable gaseous medicine based on xenon and nitrous oxide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhalable gaseous medicine based on xenon and nitrous oxide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhalable gaseous medicine based on xenon and nitrous oxide will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1632365